Semaglutide, the active ingredient in Ozempic and Wegovy, is a glucagon-like peptide-1 (GLP-1) receptor agonist taken as a once-weekly injection. It’s administered with a tiny needle that punctures ...
If you’re considering a semaglutide medication like Ozempic or Wegovy for weight loss, you may be a bit worried about the weekly injections. Both medications come in a pre-filled pen so you can inject ...
As of February 2025, the semaglutide injection (Ozempic, Wegovy) shortage was resolved. As a result, compounded semaglutide ...
The Food and Drug Administration has approved the first GLP-1 pill for weight loss and maintenance. Drugmaker Novo Nordisk ...
Telehealth Provider Offers FDA-Approved and Compounded Weight Loss Medications in All 50 States, Subject to Regulations ...
Novo Nordisk announced today that Health Canada has issued marketing authorization with conditions [Notice of Compliance with ...
Semaglutide, the active ingredient in the injectable diabetes drug Ozempic and its weight-loss sister prescription Wegovy, seems to have yet another unfortunate side effect: putting back on the weight ...
Bengaluru: New findings presented at ObesityWeek® 2025 have unveiled promising results for an investigational daily pill version of the weight-loss drug semaglutide (often known by the brand ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback